FDA.reportPublic FDA data

0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]

RxCUI
1986830
RxNorm name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]
Display name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]
Full name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125614ShingrixZoster Vaccine Recombinant, Adjuvanted351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0280849d-5c78-4a9d-8941-4eab429f6bd8SHINGRIX vaccine 0.5 ML Injection [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix] [SBD] · 0.5 ML Shingrix 0.1 MG/ML Injection [SY] · Shingrix vaccine 0.5 ML Injection [SY]423These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
279a251c-f4d0-4c47-b999-7ef1a45ac0d0SHINGRIX vaccine 0.5 ML Injection [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix] [SBD] · 0.5 ML Shingrix 0.1 MG/ML Injection [SY] · Shingrix vaccine 0.5 ML Injection [SY]46These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
e9ba0102-8cbb-4c4c-810e-292119095a8aSHINGRIX vaccine 0.5 ML Injection [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix] [SBD] · 0.5 ML Shingrix 0.1 MG/ML Injection [SY] · Shingrix vaccine 0.5 ML Injection [SY]42These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415